420PPhase I/II study of ODM-203, a selective dual FGFR/VEGFR inhibitor, in patients with advanced solid tumours. (23rd October 2018) - Bono, P; Massard, C; Peltola, K; Azaro, A; Italiano, A; Kristeleit, R S; Lassen, U N; Arkenau, H-T; Hakulinen, P; Garratt, C; Ikonen, T; Mustonen, M; et al.